Cormorant Asset Management, LP - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 176 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$27,950,000
+3.7%
184,8940.0%1.95%
-4.1%
Q2 2022$26,941,000
+184.0%
184,894
+131.1%
2.04%
+179.8%
Q1 2022$9,486,000
-30.6%
80,000
-60.0%
0.73%
+138.7%
Q1 2021$13,670,000
-62.5%
200,000
-52.9%
0.30%
-64.8%
Q4 2020$36,427,000
+12.1%
425,000
-15.0%
0.87%
-30.6%
Q3 2020$32,505,000
-25.9%
500,000
-16.7%
1.25%
-25.3%
Q2 2020$43,866,000
+47.2%
600,000
-31.5%
1.67%
+21.0%
Q1 2020$29,795,000
-63.5%
875,551
-41.6%
1.38%
-57.5%
Q4 2019$81,660,000
+4.0%
1,500,000
-20.3%
3.26%
-31.8%
Q3 2019$78,492,000
-14.6%
1,881,400
-10.4%
4.78%
-9.5%
Q2 2019$91,960,000
+62.4%
2,100,000
+90.9%
5.28%
+38.0%
Q1 2019$56,617,000
+135.5%
1,100,000
+69.2%
3.83%
+96.1%
Q4 2018$24,037,000
+146.2%
650,000
+150.0%
1.95%
+207.4%
Q3 2018$9,763,000
-13.2%
260,000
-8.7%
0.64%
-23.8%
Q2 2018$11,253,000
+53.4%
284,7350.0%0.83%
+52.3%
Q1 2018$7,335,000
-8.7%
284,735
-4.4%
0.55%
-35.0%
Q4 2017$8,035,000297,8030.84%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
UBS OCONNOR LLC 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders